Financial Statements and Related Announcement::Half Yearly Results

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
Financial Statements and Related Announcement
Date &Time of Broadcast
13-Nov-2018 22:42:43
Status
New
Announcement Sub Title
Half Yearly Results
Announcement Reference
SG181113OTHREYT9
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Ltd
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
13/11/2018 19:25:00
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format)
We wish to inform you that Board has today at its meeting approved the Unaudited Financial Results for the Second and Half Year ended September 30, 2018.

The copy of the said results together with Management Discussion & Analysis, Press Release and Limited Review Report of the Auditors is enclosed herewith.

These are also being made available on the website of the Company at www.glenmarkpharma.com.

Additional Details

For Financial Period Ended
30/09/2018

Attachments

SGX_Result.pdf
Total size =1137K